1. Antibiotic resistance: additional federal actions needed to better determine magnitude and reduce impact Publication: Washington, DC : United States Government Accountability Office, March 2020 Subject(s): Bacterial Infections -- therapyDrug Resistance, BacterialDiagnostic Techniques and ProceduresEpidemiological MonitoringGovernment RegulationUnited StatesCenters for Disease Control and Prevention (U.S.)
2. Public health: federal programs provide screening and treatment for breast and cervical cancer : report to the chairman, Committee on Finance, U.S. Senate Publication: Washington, DC : United States Government Accountability Office, October 2020 Subject(s): Breast Neoplasms -- diagnosisEarly Detection of CancerMedicaidUterine Cervical Neoplasms -- diagnosisUnited StatesCenters for Disease Control and Prevention (U.S.)
3. Maternal mortality: trends in pregnancy-related deaths and federal efforts to reduce them : Congressional requesters Publication: Washington, DC : United States Government Accountability Office, March 2020 Subject(s): Government RegulationHealth Status DisparitiesMaternal Mortality -- trendsMinority Health -- statistics & numerical dataWomen's Health -- statistics & numerical dataUnited StatesCenters for Disease Control and Prevention (U.S.)
4. Maternal mortality and morbidity: additional efforts needed to assess program data for rural and underserved areas : report to the Committee on Ways and Means, House of Representatives Publication: Washington, DC : United States Government Accountability Office, April 2021 Subject(s): Government RegulationMaternal MortalityMedically Underserved AreaPregnancy Complications -- epidemiologyUnited StatesUnited States. Department of Health and Human ServicesCenters for Disease Control and Prevention (U.S.)
